Innovation Pharmaceuticals Inc. Share Price
Equities
IPIX
US45782D1000
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | -40.00% | -57.14% | -69.39% |
02-01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
Sales 2022 | 0.02 1.44 | Sales 2023 | - | Capitalization | 10.37M 830M |
---|---|---|---|---|---|
Net income 2022 | -7M -561M | Net income 2023 | -3M -240M | EV / Sales 2022 | 673,326,722 x |
Net cash position 2022 | 2.52M 202M | Net cash position 2023 | 793K 63.51M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.22
x | P/E ratio 2023 |
-3.19
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.87% |
1 day | -40.00% | ||
1 week | -57.14% | ||
Current month | -89.51% | ||
1 month | -89.29% | ||
3 months | -78.57% | ||
6 months | -81.71% | ||
Current year | -69.39% |
Managers | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 19/06/07 |
Jane Harness
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/08/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 19/06/07 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 0.0015 | -40.00% | 200 |
29/04/24 | 0.0025 | -16.67% | 102,000 |
26/04/24 | 0.003 | +50.00% | 161,805 |
25/04/24 | 0.002 | -20.00% | 204,500 |
24/04/24 | 0.0025 | -28.57% | 467,101 |
Delayed Quote OTC Markets, April 30, 2024 at 04:04 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-69.39% | 794K | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.32% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- IPIX Stock